Ads
related to: ischemic hepatitis treatments and drugs side effects tablewiserlifestyles.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
Ischemic hepatitis, also known as shock liver, is a condition defined as an acute liver injury caused by insufficient blood flow (and consequently insufficient oxygen delivery) to the liver. [5] The decreased blood flow ( perfusion ) to the liver is usually due to shock or low blood pressure.
Other side effects include allergic reactions and reactivation of hepatitis B among those previously infected. [6] Use is not recommended in those with significant liver problems . [ 6 ] While there is no evidence of harm with use during pregnancy , this use has not been well studied. [ 6 ]
Drugs: People with hepatitis should avoid taking drugs metabolized by the liver. [17] Glucocorticoids are not recommended as a treatment option for acute viral hepatitis and may even cause harm, such as development of chronic hepatitis. [17] Precautions: Universal precautions should be observed. Isolation is usually not needed, except in cases ...
Elbasvir/grazoprevir, sold under the brand name Zepatier, is a fixed-dose combination for the treatment of hepatitis C, containing elbasvir (an inhibitor of hepatitis C virus's NS5A protein) and grazoprevir (an NS3/4A inhibitor). It is used to treat chronic hepatitis C virus (HCV) genotypes 1 or 4 infection in both treatment-naïve and ...
Telaprevir (VX-950), marketed under the brand names Incivek and Incivo, is a pharmaceutical drug for the treatment of hepatitis C co-developed by Vertex Pharmaceuticals and Johnson & Johnson. It is a member of a class of antiviral drugs known as protease inhibitors . [ 3 ]
Treatments for heart failure include medications, an intra-aortic balloon pump, a ventricular assist device, heart valve replacements, extracorporeal membrane oxygenation (if the heart failure worsens suddenly and especially if an infection was the cause), an artificial heart, or a heart transplant (from a deceased human donor, or from a pig ...
Hepatitis A and hepatitis B can be prevented by vaccination. Effective treatments for hepatitis C are available but costly. [6] In 2013, about 1.5 million people died from viral hepatitis, most commonly due to hepatitis B and C. [6] East Asia, in particular Mongolia, is the region most affected. [6]
Expression of direct-acting NS5B inhibitors does not take place in cells that are not infected by hepatitis C virus, which seems to be beneficial for this class of drugs. [3] Low efficacy, serious side effects, development of resistance of previously available hepatitis C treatments were the greatest concerns prior to the development of direct ...